Academician LIU Liang

Academician LIU Liang (7th COT Award Winner)

Academician Liu Liang Academician Liu Liang
Affiliation at the time of the Award:

  • Academician of the Chinese Academy of Engineering
  • Fellow of National Academy of Inventors
  • Professor, Director of the Academic Committee, Director of the State Key Laboratory of Traditional Chinese Medicine Syndrome, and Dean of the Institute of Integrated Traditional Chinese and Western Medicine Innovation at Guangzhou University of Chinese Medicine
  • Chief Scientist, Guangdong Academy of Traditional Chinese Medicine
  • Honorary President, Chair Professor and the then Director of State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology
  • Project Advisor for Traditional Medicine, World Health Organization
  • Convener, Working Group 1 of the International Organisation for Standardisation Technical Committee on Traditional Chinese Medicine (ISO/TC249)　
  • Founding and Executive Member, Consortium for Globalization of Chinese Medicine

 

Biography

Liu Liang, M.D., is an Academician of the Chinese Academy of Engineering, Fellow of the US National Academy of Inventors, member of the Academic Division of the Chinese Academy of Medical Sciences, member of the Academic Division of the China Academy of Chinese Medical Sciences, and former President of the Macau University of Science and Technology.

Academician Liu currently serves as the Chairman of the Academic Committee, First-class Professor, Director of the State Key Laboratory of Chinese Medicine Syndrome at Guangzhou University of Chinese Medicine, and the Chief Scientist of Guangdong Provincial Academy of Traditional Chinese Medicine. He also holds positions as the Consultant and Chair of the expert group for the World Health Organization Traditional Medicine Program, Convener of the first working group of the ISO/TC249 Technical Committee on Traditional Chinese Medicine of the International Organization for Standardization (ISO), Director of the Chinese Society of Immunology’s Committee on Traditional Chinese Medicine and Immunology, Vice-President of the World Federation of Chinese Medicine Societies (WFCMS), and Honorary Chairman of the Committee on Traditional Chinese Medicine and Immunology of WFCMS.

As a renowned expert in Chinese medicine rheumatology, Academician Liu is a leading figure in integrating multidisciplinary frontier technologies in Chinese medicine research. He has published 350 research papers in SCI-indexed academic journals and authored/edited 18 publications and textbooks. As the first inventor, he has obtained 52 patents authorised both domestically and internationally. He has received 24 awards and honorary titles, including two second-class National Science and Technology Progress Awards, two first-class Natural Science Awards from the Ministry of Education of China, the first National Innovation Pioneer Award, recognition as a National Young and Middle-aged Expert with Outstanding Contributions, the Shulan Medical Award, Certificates of Merit from the Macao SAR Government, Honorary Citizenship of Zhuhai City, Guangdong Province, and Honorary Citizenship of Huaihua City, Hunan Province.

Academician Liu spearheaded the development of Zhengqing Fengtongning, the world’s first rheumatic drug targeting prostaglandin E2 synthase-1, and the only monomolecular Chinese medicine drug included in the National Essential Medicines List, which was widely used across China. He also led his team in the international pioneering development of the titanium dioxide-PGC chip, establishing the world’s most sensitive quantitative glycomics analysis technology and innovating new methods for diagnosing rheumatoid arthritis and other rheumatic diseases.

Academician Liu has long been engaged in higher education management and scientific research in the Guangdong-Hong Kong-Macao Greater Bay Area, making significant contributions to the development and advancement of higher education and Chinese medicine science and technology in these three areas, as well as to the globalisation of traditional Chinese medicine.

 

 

Return